Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-06-04 @ 7:05 PM
Study NCT ID:
NCT02899195
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2016-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Sponsor:
PrECOG, LLC.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PrE0505
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |